Polymyalgia Rheumatica clinical trials
The registry lists 135 studies for Polymyalgia Rheumatica across more than 10 countries. 28 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-22.
Status
- Completed
- 65
- Recruiting
- 21
- Terminated
- 17
- Status unknown
- 15
- Active, not recruiting
- 8
- Not yet recruiting
- 7
Phase
- Phase 3
- 26
- Phase 2
- 25
- Phase 4
- 7
- Phase 1
- 7
Where
- France
- 47
- United States
- 33
- Germany
- 22
- United Kingdom
- 19
- Denmark
- 19
- Italy
- 15
Who runs them
University Hospital, Brest (13) · Novartis Pharmaceuticals (5) · Centre Hospitalier Universitaire Dijon (5) · University of Bonn (5) · University of South Florida (4) · University of Oxford (3) · Sanofi (3) · University of Aarhus (3)
Studies
Recruiting first, then most recently updated. Showing 50 of 135 — search for more.
- Sarilumab Efficacy and Safety in Adults With Early Polymyalgia RheumaticaRecruitingNCT07286214Phase 49 countries
- DNA Methylation in PMRNot yet recruitingNCT07748195
- Justification And Evaluation of Baricitinib Plus Corticosteroids Versus corticosteroiDs Alone in pOlymyalgia RhEumaticaRecruitingNCT07279688Phase 31 country
- Using Personalized Rehabilitation to Reduce Disease and Increase Activity of Patients With Polymyalgia RheumaticaNot yet recruitingNCT07749547Not applicable
- Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder ArthroplastyRecruitingNCT07138898Phase 21 country
- Justification of the Initial Diagnosis and Evaluation of the Overall Evolution of a Cohort of Recent Polymyalgia Rheumatica (JADORE)Not yet recruitingNCT071321641 country
- A Qualitative Assessment of the Severity and Impact of Rheumatic Immune-Related Adverse Events Following Immune Checkpoint Inhibitor ImmunotherapyRecruitingNCT066471341 country
- Effect of Supplemental Hydrocortisone During Stress in Prednisolone-induced Adrenal InsufficiencyRecruitingNCT05435781Phase 41 country
- Rheumatology Patient Registry and BiorepositoryRecruitingNCT044020861 country
- Study of the Association Between Sacroiliitis/Axial Spondylarthritis and Giant Cell Arteritis/ Polymyalgia RheumaticaNot yet recruitingNCT073944781 country
- Hydrocortisone and Placebo in Patients With Symptoms of Adrenal Insufficiency After Cessation of Glucocorticoid TreatmentRecruitingNCT05193396Phase 41 country
- Using Novel Imaging to Rethink Diagnostic and Treatment Strategies for Polymyalgia RheumaticaRecruitingNCT070104841 country
- Pilot Study to evaluateThrombomodulin to Rule Out Giant Cell Arteritis (GCA) in Polymyalgia Rheumatica (PMR) Patients. (THROPIQ)RecruitingNCT066096681 country
- Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and EfficacyRecruitingNCT071500001 country
- Performance of a Fast-track Pathway for Giant Cell Arteritis DiagnosisRecruitingNCT067426711 country
- AYLo - AutoimmunitY and Loss of yRecruitingNCT066960271 country
- Assessing Biomarker in Giant Cell Arteritis and Polymyalgia RheumaticRecruitingNCT064601421 country
- Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory DiseasesRecruitingNCT059043011 country
- Predictive Factors for Treatment Response in Patients With Newly-diagnosed Polymyalgia Rheumatica and Giant Cell ArteritisRecruitingNCT054794481 country
- Clinical and Immunogenetic Characterization of Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR)RecruitingNCT041029301 country
- A Registry Study Assessing PRO, Dosing Patterns, and Safety of Vunakizumab in Patients With General Rheumatic Diseases.Not yet recruitingNCT067665521 country
- TocILizumab in aorTitis in GCA (TILT)RecruitingNCT062710181 country
- Diagnostic Performance of 18-FDG PET-CT Scores for the Diagnosis of Polymyalgia RheumaticaNot yet recruitingNCT065583571 country
- Visual Involvement in Giant Cell ArteritisRecruitingNCT065007281 country
- Post-therapeutic Imaging Evaluation of Patients With Horton's Disease (Giant Cell Arteritis) (EvHortim)RecruitingNCT060041541 country
- Investigation of the Influence of the Human Microbiome on Giant Cell ArteritisRecruitingNCT062790651 country
- Clonal Hematopoiesis in Giant Cell ArteritisNot yet recruitingNCT06244069
- DANIsh VASculitis Database (DANIVAS)RecruitingNCT059357091 country
- Induction and Tapering Therapy With Tofacitinib and Glucocorticoid in Patients With Polymyalgia RheumaticaCompletedNCT06172361Phase 31 country
- Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR)Active, not recruitingNCT06331312Phase 322 countries
- Efficacy and Safety of Olokizumab in Patients With Polymyalgia Rheumatica (PROMISE)Active, not recruitingNCT07670546Phase 31 country
- Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Polymyalgia Rheumatica (PMR)CompletedNCT05767034Phase 326 countries
- PRediction Of DIverse Glucocorticoids toxIcity OUtcomeSActive, not recruitingNCT046644651 country
- Abatacept in earLy Onset Polymyalgia Rheumatica: Study ALORSCompletedNCT03632187Phase 31 country
- Risk of Diabetes Mellitus in Patients With Giant Cell Arthritis and Polymyalgia Rheumatica.CompletedNCT060115121 country
- Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Intravenous Secukinumab in Patients With GCA or PMRCompletedNCT06130540Phase 16 countries
- Efficacy and Safety of Secukinumab in Patients With New Onset of Giant Cell Arteritis Who Are in Clinical RemissionCompletedNCT05380453Phase 31 country
- Rituximab Effect on Decreasing glUcoCorticoid Exposition in PolyMyalgia Rheumatica Patients Experiencing a PMR RelapseActive, not recruitingNCT05533164Phase 31 country
- Rituximab Effect on Decreasing glUcoCorticoid Exposition in PolyMyalgia Rheumatica Patients Recently DiagnosedCompletedNCT05533125Phase 31 country
- Treat-to-target Prednisolon Taper in Patients With Polymyalgia RheumaticaActive, not recruitingNCT05636501Not applicable1 country
- Improved Diagnostics and Monitoring of Polymyalgia RheumaticaActive, not recruitingNCT045195801 country
- Biologics in Refractory Vasculitis: A Trial of Biologic Therapy for Refractory Primary Non-ANCA Associated VasculitisTerminatedNCT05168475Phase 21 country
- A Trial of Prednisolone in Combination With SPI-62 in Participants With Polymyalgia Rheumatica (PMR)TerminatedNCT06281236Phase 11 country
- A Trial of Prednisolone in Combination With SPI-62 or Placebo in Subjects With Polymyalgia Rheumatica (PMR)CompletedNCT05436652Phase 22 countries
- Giant Cell Arteritis - Optimization of DiagnosticsCompletedNCT052489061 country
- Validation of the PMR Activity Score and Evolution of Patient-reported Outcomes in Patients With Polymyalgia RheumaticaCompletedNCT055423161 country
- Validation of a Diagnostic Algorithm of Giant Cell ArteritisCompletedNCT02703922Not applicable1 country
- A Study to Evaluate the Change in Disease State and Adverse Events in Adult Participants With Polymyalgia Rheumatica (PMR) Dependent on Glucocorticoid Treatment, Receiving Subcutaneous Injections of ABBV-154TerminatedNCT04972968Phase 215 countries
- Ustekinumab for the Treatment of Relapse of Refractory Giant Cell ArteritisCompletedNCT03711448Phase 21 country
- Histopathological Analysis of Temporal Artery Biopsy Following Dynamic Full-field Optical Coherence Tomography, a Comparison to Conventional Histopathological Findings in Patients With Suspected Giant Cell Arteritis (DOCTA)CompletedNCT056633331 country